Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW domain binding protein 1-like pseudogene 5 (WBP1LP5) is a pseudogene annotated in Homo sapiens[7][3]. Pseudogenes are typically non-functional DNA sequences similar to known protein-coding genes but do not produce a functional protein. WBP1LP5 shares sequence similarity with the protein-coding gene WBP1L but has no confirmed coding potential, no evidence of translation, no documented biological role, and no known involvement in disease or drug response[7][3][4]. The canonical molecular classification for WBP1LP5 is “pseudogene.” If the query intended a therapeutic or functional biomolecule, this entry is not appropriate, as WBP1LP5 is not a functional gene product, receptor, or drug target[7]. The relevant therapeutic target would instead be the parent protein-coding gene, **WW domain binding protein 1 like (WBP1L)**, which is linked to hematopoietic regulation and has some disease biomarker relevance, but not the pseudogene[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain binding protein 1-like pseudogene 5 (WBP1LP5).